Planning

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Preliminary Market Engagement Notice: Targeted Prostate Cancer Screening Programme - PSA Testing, MRI Reporting and BRCA Digital Decision Resource

NHS England

This public procurement record has 1 release in its history.

Planning

05 Aug 2026 at 15:30

Planning Notice
Summary of the contracting process

NHS England is undertaking early market engagement for a targeted prostate cancer screening programme for men at increased risk, including men with a known pathogenic or likely pathogenic BRCA2 variant. The proposed scope covers three connected but potentially separate workstreams: PSA laboratory processing and pathway support; prostate MRI reporting; and development and evaluation of a BRCA digital decision resource or website. This is primarily a healthcare services requirement, including medical laboratory, medical analysis and imaging services, with a digital development element. The work is intended to support screening pathways across the United Kingdom. NHS England is seeking to understand how the different provider markets could deliver these requirements and how the workstreams should interface.

This is a planned preliminary market engagement at the intention-to-procure stage, not a call for competition or a current tender. NHS England expects to use the engagement to test market capability, delivery models, mobilisation, risks, pricing assumptions, digital and information governance, pathway interfaces and possible routes to market. The three workstreams may be procured separately and may use different procedures. Subject to approvals, the PSA and MRI workstreams are anticipated to use the Provider Selection Regime where applicable, while the digital workstream is anticipated to follow the Procurement Act 2023. NHS England currently expects the next notice to be published on 7 December 2026. No contract value or budget is stated.

The engagement is likely to suit clinical laboratories able to process PSA tests and support diagnostic pathways, specialist providers with prostate MRI reporting capability, and digital health or software companies able to develop and evaluate patient or clinician decision resources. Businesses may respond to one, two or all three workstreams, so collaboration between laboratory, imaging, clinical, digital and evaluation specialists could be relevant. NHS England is particularly seeking evidence about delivery models, mobilisation requirements, pathway interfaces, pricing assumptions, information governance and route-to-market options. Suppliers should be ready to explain their operational capacity, relevant screening or diagnostic experience, digital development and evaluation capability, and ability to work within NHS clinical and information-governance requirements.

How relevant is this notice?

Notice Information

Notice Title

Preliminary Market Engagement Notice: Targeted Prostate Cancer Screening Programme - PSA Testing, MRI Reporting and BRCA Digital Decision Resource

Notice Description

NHS England is undertaking early market engagement to inform three separate requirements within the Targeted Prostate Cancer Screening Programme.

Lot Information

Lot 1

Preliminary Market Engagement / Early Market Engagement

NHS England is undertaking preliminary market engagement to inform three separate but connected requirements within the Targeted Prostate Cancer Screening Programme.

The proposed workstreams are:

1. PSA laboratory processing and pathway support;
2. prostate MRI reporting;
3. BRCA digital decision resource / website development and evaluation.

The programme is being developed to support targeted prostate cancer screening for men at increased risk, including men with a known pathogenic or likely pathogenic BRCA2 variant. The purpose of this engagement is to understand market capability, potential delivery models, mobilisation requirements, key risks, pricing assumptions, digital and information governance considerations, pathway interfaces and route-to-market options.

The workstreams involve different capabilities and provider markets. NHS England may procure the requirements separately, and different procurement routes may apply to different workstreams. NHS England is currently assessing the most appropriate route to market for each workstream. Subject to completion of the relevant approvals and assessments, Workstreams 1 and 2 are anticipated to be procured under the Provider Selection Regime where confirmed as being within scope of that regime. Workstream 3 is anticipated to be procured in accordance with the Procurement Act 2023.

This engagement is not a call for competition, does not commence a procurement process, and does not commit NHS England to any procurement, route to market, contract award or level of expenditure. Participation in this engagement is not required in order to participate in any future procurement process, and non-participation will not prevent participation in any future opportunity.

Suppliers may respond to one, two or all three workstreams, depending on their capability and interest.

The Preliminary Market Engagement Notice uses 85100000-0 Health services as the main CPV code because the engagement relates to a targeted screening programme and includes two clinical/diagnostic workstreams. Additional CPV codes have been included to reflect the specific workstreams: PSA laboratory processing and medical analysis, prostate MRI reporting, and digital decision resource / website development. The use of multiple CPV codes reflects the fact that this is one combined market engagement exercise only; the workstreams may be procured separately and may follow different procurement routes following Commercial review.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06dcb3
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/074308-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services

CPV Codes

85100000 - Health services

85145000 - Services provided by medical laboratories

85148000 - Medical analysis services

85150000 - Medical imaging services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
5 Aug 20262 months ago
Submission Deadline
Not specified
Future Notice Date
7 Dec 20262 months to go
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
Not specified
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...